| Name | Title | Contact Details |
|---|
Aircast, Inc. is a Summit, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
IEHP, Inland Empire Health Plan, is one of the top 10 largest Medicaid health plans and the largest not-for-profit Medicare-Medicaid plan in the country. With a network of more than 7,300 providers and 2,500 employees, IEHP serves over 1.4 million residents in Riverside and San Bernardino counties who are enrolled in Medicaid or Cal MediConnect Plan (Medicare-Medicaid Plan). Through a dynamic partnership with Providers and community, award-winning service and innovative products, IEHP is fully committed to advocating for our Members and providing them with quality, accessible and wellness-based health care services.
Calimmune, Inc., a clinical-stage human immunodeficiency virus (HIV) gene medicines company, develops cell-based therapies for HIV. The company offers Cal-1, a gene-based stem cell therapy to protect individuals infected with HIV from progressing to AIDS. It also focuses on developing products to address the needs of various types of individuals at different states of HIV infection and with different levels of treatment experience..
Dycem USA is a Warwick, RI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Since 1968 our goal has been straightforward: help patients get their life back on track and achieve a life of sobriety, free from drug use and symptoms of mental illness. A life that is productive, socially responsible and healthy. Gateway Foundation is one of the nation`s largest nonprofit provider of substance use disorder treatment and a nationally recognized leader in the field of addiction medicine. With treatment programs in Florida, Georgia, Illinois, Michigan, Missouri, New Jersey, Texas and Wyoming we specialize in substance use disorders for patients diagnosed with substance use disorder and mental health disorders. Gateway Foundation`s professional clinicians support over 9,000 people a day to successfully complete treatment by developing a personalized plan to treat the underlying causes of substance use disorder—not just their addiction to drugs or alcohol.